Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:ICPNYSE:STJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICPBelgravia Capital International Inc,C$0.00C$0.02▼C$0.12C$14.59MN/A698,779 shs8.14 million shsSTJSt Jude Medical$80.82$0.00$48.83▼$84.00N/AN/A8.54 million shsN/A20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICPBelgravia Capital International Inc,0.00%0.00%0.00%0.00%0.00%STJSt Jude Medical0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationICPBelgravia Capital International Inc,N/AN/AN/AN/AN/AN/AN/AN/ASTJSt Jude MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICPBelgravia Capital International Inc, 0.00N/AN/AN/ASTJSt Jude Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICPBelgravia Capital International Inc,N/AN/AN/AN/AN/AN/ASTJSt Jude MedicalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICPBelgravia Capital International Inc,N/AN/A0.00N/AN/AN/AN/AN/AN/ASTJSt Jude MedicalN/A$5.8713.77∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthICPBelgravia Capital International Inc,N/AN/AN/AN/AN/ASTJSt Jude Medical$1.241.53%N/A21.12%N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICPBelgravia Capital International Inc,N/ASTJSt Jude Medical82.73%Insider OwnershipCompanyInsider OwnershipICPBelgravia Capital International Inc,N/ASTJSt Jude Medical4.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableICPBelgravia Capital International Inc,147,000243.24 millionN/ANot OptionableSTJSt Jude MedicalN/AN/AN/AOptionableTRIG, ICP, SDRC, and STJ HeadlinesRecent News About These CompaniesFighting Sickle Cell: How St. Jude and Donors Gave Avery a New Lease on LifeApril 29, 2025 | msn.comOne Step at a Time: How St. Jude and Supporters Helped Arielle Walk AgainApril 29, 2025 | msn.comSt. Jude Rock and Roll Music City marathon marks 25th anniversary this weekendApril 26, 2025 | newschannel5.comTopeka Dream Home helps St. Jude patients across the U.S.April 24, 2025 | msn.comLocal companies donate materials, labor for St. Jude Dream Home GivewayMarch 28, 2025 | msn.comA St. Jude superhero—this doctor has dedicated her life to treating cancer patientsMarch 22, 2025 | msn.comLocal representative fighting for St. Jude medical care in CharlestonMarch 18, 2025 | msn.com'St. Jude for pets': Decatur vet launching nonprofit research hospital to study diseases affecting humans and animalsMarch 12, 2025 | msn.comSt. Jude, UT, Vanderbilt push to keep NIH fundingFebruary 20, 2025 | dailymemphian.comProposed federal-funding cuts could come at a cost for St. Jude, UTHSCFebruary 12, 2025 | dailymemphian.comCould NIH funding cut affect St. Jude Children's Research Hospital? Here's what we knowFebruary 11, 2025 | msn.comNIH cuts could hurt research at St. Jude, UTFebruary 11, 2025 | msn.comSt. Jude creates new leadership roleJanuary 24, 2025 | beckershospitalreview.comEvidence still under review for suspects in 2023 shooting death of St. Jude doctorJanuary 16, 2025 | wreg.comOklahoma Family Bakes For A Cause To Help St. Jude Children's HospitalDecember 24, 2024 | newson6.comSt. Jude names executive vice president and chief administrative officerDecember 11, 2024 | msn.comSt. Jude Children’s Research Hospital plans new 16-story towerNovember 28, 2024 | msn.comSt. Jude files permit for 16-story advanced research center amid ongoing Memphis expansionNovember 27, 2024 | commercialappeal.com'It was just so shocking': St. Jude mother receives 16 automated bereavement emails in one dayNovember 27, 2024 | fox13memphis.comFormer St. Jude patient gives back to community that supported his treatmentNovember 27, 2024 | azfamily.comTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Signs of a more buyer-friendly housing market emerge for the spring homebuying seasonBy The Associated Press | April 6, 2025View Signs of a more buyer-friendly housing market emerge for the spring homebuying seasonWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For Quantum3 High Short Interest Stocks Set to Pop After Tariff Fears FadeBy Gabriel Osorio-Mazilli | April 17, 2025View 3 High Short Interest Stocks Set to Pop After Tariff Fears FadeTRIG, ICP, SDRC, and STJ Company DescriptionsBelgravia Capital International Inc, TSE:ICPBelgravia Capital International Inc, formerly known as IC Potash Corp, is a Canada-based company focused on the provision of value-added services to the international Cannabis industry. The Company's activities include the production of specialized organic fertilizers for Cannabis plants, as well as research and development in the area of agronomics through its wholly owned subsidiary, ICP Organics Corp. Additionally, the Company is engaged in the development of blockchain technology software to support the cultivation and distribution processes, such as seed to sale tracking and quality attestation of intermediate and consumer products. The Company is also developing a royalty-streaming subsidiary.St Jude Medical NYSE:STJSt. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Top-Ranked Insider Buys From April by Market Cap Palantir Stock Drops Despite Stellar Earnings: What's Next? Hims & Hers Stock Rises on Fundamentals and Squeeze Potential Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership? D-Wave Quantum: Hidden Opportunity or Short Seller's Dream? Microsoft Stock After Xbox Price Hike: Buy or Hold? Uncertainty Creates Opportunity for Tyson Foods Investors Why Wells Fargo Is Buying $40 Billion of Its Own Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
